Clinical trial
Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent…
NCT00288275 · Precision Therapeutics, Industry · Terminated
Key facts
| NCT number | NCT00288275 |
|---|---|
| Title | Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer |
| Official title | A Non-Interventional Prospective Study of the Correlation of the Precision Therapeutics, Inc. Chemoresponse Assay With Progression-Free Survival in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer. |
| Lead sponsor | Precision Therapeutics, Industry |
| Status | Terminated |
| Study type | Observational |
| Conditions | Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms |
| Enrollment | 256 |
| Start date | Jul 1, 2004 |
| Completion | Oct 1, 2012 |
| First posted | Feb 7, 2006 |
| Last update posted | Oct 5, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: